🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very late pruning in the rain

Feeding the swans and there new cygnets at our fishing lake

What a wonderful day - we had singing, dancing, bouncing, exploring, playing & plenty of smiling! We could not have asked for more. A giant thank you to all our wonderful staff for sacrificing their weekend & helping make the Little Oaks Nursery School launch such a success!

A bee orchid by our fishing lake

Soon you will be able to stay on our vineyard

Keep George At His Happy Place gofundme.com/f/keep-george-…

Got are new tractor from N.P.Seymour today

#dddd

1/2 #RECOVERYtrial results with #dexamethasone (DXM) a major milestone in treatments for #COVID_19 and reinforce the importance of modulating the immune system to control progression of symptoms. 4D pharma's MRx-4DP0004 has complementary MoA to glucocorticoids incl. DXM...

2/2 ...and is already being added to glucocorticoids in our asthma trial. If DXM becomes standard of care for #COVID_19 we see strong rationale for investigating MRx-4DP0004 as an add on therapy, which could be investigated in 4D pharma's current Phase II COVID-19 study

Gastro inflammation links to greater risk of dementia & earlier onset. 4D pharma #DDDD is leveraging gut-brain axis to treat CNS conditions & has identified #livebiotherapeutics with demonstrated anti-inflammatory, #gut barrier & neuroprotective effects tinyurl.com/y888gm5t

4D pharma #DDDD treats first #cancer #patients in Part B of Phase I/II combination #clincaltrial of MRx0518 & #Keytruda with acquired resistance to prior #immune #Checkpoint #therapy, opening 4 additional trial sites in US. tinyurl.com/y8ldgoxe

Great VJ Oncology interview with Alex Stevenson CSO, 4D pharma #DDDD, discussing first #cancer #patients treated with MRx0518 in Part B of Phase I/II trial with #Keytruda & potential for #livebiotherapeutics in #oncology. View link tinyurl.com/yab5jh3v

4D pharma #DDDD CEO Duncan Peyton's interview with @proactive_UK on MRx0518 as Part B of Phase I/II trial with #Keytruda starts, adding news sites to accelerate enrollment expanding on PoC in Part A. Also discuss #Merck collab, LBPs in CNS and more tinyurl.com/y98pe4hj

4D pharma $DDDD will be at ChinaBio® Group this week meeting (virtually) potential partners and investors to discuss our MicroRx #platform and #livebiotherapeutic candidates across a range of therapeutic areas #ChinaBio ChinaBio® Today #DDDD

Duncan Peyton, CEO 4D pharma talks to @proactive_UK Katie Pilbeam about our exciting #cancer results announced this morning - seeing durable responses in advanced heavily pre-treated patients. Also discussing the future of the trial, MRx0518 and 4D #DDDD $DDDD

The new winery starting to take shape

Not long to go now 6 weeks till launch baileyhills.co.uk